Range Cancer Therapeutics ETF (CNCR) Holdings → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free CNCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HoldingsStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial Media Top 50 CNCR HoldingsRankCompanyCurrent PriceWeightShares Held1GERNGeron$3.79+6.5%2.78%164,0132ACRVAcrivon Therapeutics$8.46-0.1%2.54%56,6123ELVNEnliven Therapeutics$17.18+2.4%2.20%24,8724JANXJanux Therapeutics$47.39+0.6%1.82%7,5995NUVBNuvation Bio$2.68+2.3%1.75%131,0616TSVT2seventy bio$4.26-0.9%1.67%72,481 Get the Latest News and Ratings for CNCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter. 7RVMDRevolution Medicines$35.96+1.8%1.54%8,9758PRLDPrelude Therapeutics$4.07+0.7%1.50%64,3559LYELLyell Immunopharma$2.17-1.4%1.48%129,87510ACETAdicet Bio$1.68-7.2%1.45%140,01111NRIXNurix Therapeutics$12.361.42%20,44312ITOSiTeos Therapeutics$10.80+1.9%1.41%26,75013MGNXMacroGenics$14.56+1.3%1.41%17,87214MRKMerck & Co., Inc.$131.19+0.4%1.41%2,38215DAWNDay One Biopharmaceuticals$14.92+12.9%1.40%20,22716CGEMCullinan Oncology$25.30+31.4%1.39%16,97417EXELExelixis$23.70+0.7%1.37%12,69518YMABY-mAbs Therapeutics$14.71-0.9%1.37%19,13519FHTXFoghorn Therapeutics$5.49+5.0%1.36%47,44220IBRXImmunityBio$7.35+43.8%1.36%58,45721MORMorphoSys$18.04-0.5%1.36%15,99922HCMHUTCHMED$18.16-4.4%1.35%17,10523INBXInhibrx$34.06-0.1%1.35%8,20324GLUEMonte Rosa Therapeutics$5.33-2.2%1.35%47,13025BPMCBlueprint Medicines$93.00+2.5%1.34%3,27226STROSutro Biopharma$3.421.34%71,57727AURAAura Biosciences$7.22+2.0%1.32%38,47528GMABGenmab A/S$28.15+2.5%1.32%9,47329IPHAInnate Pharma$2.46+2.5%1.32%113,89830RAPTRAPT Therapeutics$8.10+3.8%1.32%34,12931SDGRSchrödinger$23.97+2.7%1.31%11,14732BCYCBicycle Therapeutics$22.73+0.9%1.30%12,51233PGENPrecigen$1.41+0.7%1.29%200,71534SNDXSyndax Pharmaceuticals$21.06+2.4%1.28%12,67235DCPHDeciphera Pharmaceuticals$14.65+3.3%1.27%18,04036REGNRegeneron Pharmaceuticals$883.20-0.8%1.27%29937BNTXBioNTech$87.21+0.6%1.26%3,08938ERASErasca$1.89+0.5%1.26%137,99239VORVor Biopharma$1.69-0.6%1.26%155,56840BMYBristol-Myers Squibb$44.86+0.4%1.25%5,468Massive breakthrough for options traders. (Ad)A 34 year old man from central florida has uncovered a totally new way to trade options… Already this year it’s allowed real people to capture top returns of 50%... 100%... Even 200% overnight… Without using technical patterns, momentum, A.I. or any of the other commonly used strategies… Now, it’s important to mention that nothing is 100% perfect in terms of trading. Click here to see this stunning development for yourself. 41IDYAIDEAYA Biosciences$39.94+3.4%1.25%6,40742ZNTLZentalis Pharmaceuticals$11.06+0.7%1.24%20,34943APLMApollomics$0.45-4.3%1.23%479,17044IGMSIGM Biosciences$9.40+22.9%1.23%28,14045MRUSMerus$45.04+0.2%1.23%6,43546IMCRImmunocore$58.46+0.8%1.21%4,77347SWTXSpringWorks Therapeutics$45.53+3.0%1.19%5,80148RCUSArcus Biosciences$15.55+5.6%1.18%15,66749IMTXImmatics$10.01+2.4%1.18%23,91950DNAGinkgo Bioworks$0.86+10.3%1.17%270,776 Geographic ExposureUnited States94.9%Currency ExposureUSD100.0%Sector ExposureHealth Care32.6%Industry ExposureBiotechnology32.6%SubIndustry ExposureBiotechnology24.3%Pharmaceuticals2.9%Coupon Exposure4-60.3%Maturity Exposure5-100.3% Related Companies and Tools Related Companies: Horizon Kinetics Medical ETF Portfolio First Trust Nasdaq Pharmaceuticals ETF Portfolio JPMorgan Healthcare Leaders ETF Portfolio Invesco Nasdaq Biotechnology ETF Portfolio ProShares UltraShort Nasdaq Biotechnology Portfolio Principal Healthcare Innovators ETF Portfolio ProShares Ultra Nasdaq Biotechnology Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio VanEck Biotech ETF Portfolio This page (NASDAQ:CNCR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.